Clinical Trials Logo

Cognition clinical trials

View clinical trials related to Cognition.

Filter by:

NCT ID: NCT05941949 Recruiting - Healthy Clinical Trials

Nutritional Supplement's Effects on Cognition

Start date: July 5, 2023
Phase: N/A
Study type: Interventional

This is a prospective, placebo controlled study, examining the effects of dietary supplement's effects on cognition and confirming safety.

NCT ID: NCT05939544 Recruiting - Clinical trials for Cardiovascular Diseases

Impact of Milk Fat Globule Membrane Supplementation on Heart and Brain Health

Start date: July 10, 2023
Phase: N/A
Study type: Interventional

In a randomised, controlled cross-over manner, this trial aims to determine how short-term daily supplementation with a milk fat globule membrane-enriched ingredient impacts on cardiometabolic health and cognitive outcomes.

NCT ID: NCT05934422 Enrolling by invitation - Atopic Dermatitis Clinical Trials

NiPPeR Randomised Trial - Child Follow Up Study

NiPPeR Child
Start date: June 16, 2023
Phase: N/A
Study type: Interventional

There is an increasing focus on the need to optimise nutrition, lifestyle and metabolism of parents before and during pregnancy and of the infant after birth, but as yet there is limited understanding of the specific influences and of the underlying mechanisms. This study is a follow up of children from the NiPPeR trial of a nutritional drink enriched with micronutrients, myo-inositol and probiotics taken preconception and during pregnancy. In this setting we will examine the influence of parental nutrition, lifestyle and metabolism before and during pregnancy on child growth, development and well-being; ascertaining growth, adiposity, metabolism, neurobehavioural and health outcomes in the children, and characterising the underlying mechanisms. The data collected will allow identification of the contributions of parental and offspring characteristics, nutritional, lifestyle and medical factors, social and economic status, ethnicity, genetics, metabolism and microbes to promoting healthy growth, body composition and wellbeing in the children.

NCT ID: NCT05930288 Not yet recruiting - Exercise Clinical Trials

The Effect of Preoperative Walking Exercises on the Prognosis of Supratentorial Brain Tumours Patients After Craniotomy

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about in patients with supratentorial brain tumours. The main questions it aims to answer is: Can short-term preoperative walking exercise protect cognitive function in the short term after craniotomy in patients with supratentorial brain tumor and reduce the incidence of surgery-related complications? Participants will be asked to receive general care and regular walking exercises prior to surgery. Researchers will compare patients who receive only general care before surgery to see if preoperative walking exercise has an effect on postoperative prognosis.

NCT ID: NCT05920577 Recruiting - Frailty Clinical Trials

Effects of Exergames and Resistance Training

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

Frailty is a common geriatric condition with significantly increased vulnerability to stress and susceptibility of negative health-related outcomes. Sacropenia and impaired cognitive function are two major contributors to frailty. This study aims to evaluate the effects of the combined use of exergaming and resistance training in improving the frailty of nursing home residents.

NCT ID: NCT05912556 Recruiting - Cognition Clinical Trials

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

BRIGHT-Mind
Start date: July 5, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

NCT ID: NCT05911490 Completed - Cognition Clinical Trials

Effects of Breaking Sitting on Human Behaviour and Metabolic Health

Start date: December 20, 2019
Phase: N/A
Study type: Interventional

This study primarily aimed to investigate effects of breaking up prolonged sitting with intermittent brisk walking in healthy young individuals on (1) post-trial human behaviours including energy intake and physical activity under free-living conditions and (2) cognitive performance in a simulated workplace environment.

NCT ID: NCT05891054 Active, not recruiting - Physical Activity Clinical Trials

Effects of the Inclusion of Physical Activity in Secondary School Academic Classes: the ACTIVE CLASS Study

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

Study based on the inclusion of physical activity in the secondary education classroom through active breaks and physically active learning, aimed at testing its effects on the improvement of physical activity levels, sedentary time, educational indicators, cognition and physical and psychological health markers.

NCT ID: NCT05853913 Recruiting - Obesity Clinical Trials

Acute Exercise on Brain Insulin Sensitivity

Start date: May 11, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Dementia is a leading cause of death in the United States among aging adults. Brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. However, there is limited data available on how exercise impacts brain insulin resistance in aging. This study will test the effect of acute exercise on brain insulin sensitivity in middle-aged to older adults. The study will also examine cognition and cardiometabolic health in relation to brain insulin sensitivity.

NCT ID: NCT05727605 Recruiting - Glioma Clinical Trials

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

NARCiS
Start date: February 8, 2023
Phase: N/A
Study type: Interventional

The goal of this multicenter prospective longitudinal study is to study the long-term impact of multimodal treatment (chemotherapy, radiotherapy and surgery) in adult brain and base of skull tumors on neurocognitive functioning. All included patients will complete a self-report inventory (subjective cognitive functioning, QoL, confounders), a cognitive test battery, an advanced MR at multiple timepoints. Moreover, toxicity will be scored according to the CTCAEv5.0 in these patients over time.